Email ID
Password
Scrip   
Ligand to acquire Metabasis
28 October 2009
Christopher Spillane

Ligand Pharmaceuticals has stepped in to salvage what is left of Metabasis Therapeutics by agreeing to acquire the beleaguered firm for $3.2 million in cash. Both companies' boards of directors have unanimously approved the deal.

Ligand said it would commit at least $8 million in R&D funding...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36